#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Nuclear Factor kappa B in the Treatment of Inflammatory and Tumor Diseases


Authors: M. Xeníček;  L. '• 'muchová;  L. L' 'vítek
Authors‘ workplace: Ústav klinické biochemie a laboratorní diagnostiky 1. LF UK a VFN, Praha 2 IV. interní klinika 1. LF UK a VFN, Praha
Published in: Čas. Lék. čes. 2004; : 680-684
Category:

Overview

Since its discovery in 1986 nuclear factor kappa B attracted attention of scientists all over the world. Intensiveresearch has proved its indisputable role in pathogenesis of particularly inflammatory and tumor diseases and revealedmany possibilities in the modulation of its function. For some of the modulators distinct therapeutic effects hávebeen proved in in vitro and in vivo studies oř even in the clinical trials, some of them are still to be tested. One mayexpect wide use of different inhibitors oř modulators of nuclear factor kappa B in various indications, which willmarkedly enhance the therapeutic effect

Key words:
apoptosis, nuclear factor kappa B, tumorigenesis, tumors, therapy, inflammation.

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#